Usefulness of sodium-glucose cotransporter 2 inhibitors for primary prevention of heart failure in patients with type 2 diabetes mellitus
Arbel R, Aboalhasan E, Hammerman A, Azuri J
Am J Cardiol. Pub. online 15 May 2021
Leggi
Arbel R, Aboalhasan E, Hammerman A, Azuri J
Am J Cardiol. Pub. online 15 May 2021
Leggi
Cherney DZI, Charbonnel B, Cosentino F, et al.
Diabetologia 2021;64:1256-67.
Leggi
Syn NL, Cummings DE, Wang LZ, et al.
Lancet. 2021;S0140-6736(21)00591-2.
Leggi
O’Donoghue ML, Kato ET, Mosenzon O, et al.
Diabetologia. 2021;64:1226-34.
Leggi
Tundindor D, Meek C, Yamamoto JM, et al.
Diabetes Technol Ther. Pub. online 4 May 2021
Leggi
Scoccimarro D, Cipani G, Dicembrini I, Mannucci E
Diabetes Care. 2021;dc210308
Leggi
Kernan WN, Inzucchi SE
Stroke. 2021;52(5):1557-1560
Leggi
Zhou Z, Jardine MJ, Li Q, et al.
Stroke. 2021;52(5):1545-1556
Leggi
Commodore-Mensah Y, Lazo M, Tang O, et al.
Diabetes Care. 2021;dc202227
Leggi
Adler A, Agodoa L, Algra A, et al.
The Lancet. Pub. online 1 May 2021
Leggi